fluticasone propionate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
FLIXOTIDE CFC-Free Fluticasone propionate 125 microgram/dose inhalation metered dose aerosol can
AUST R: 63447
Active ingredients:
fluticasone propionate

Dosage form:
Inhalation, pressurised

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

From
18 Sep 2024
to
31 Jan 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
Sponsor is working to expedite the next shipment. Alternative generic products are available.

FLUTICASONE CIPLA INHALER fluticasone propionate 125 microgram/actuation inhalation pressurised aerosol can metered dose
AUST R: 270515
Active ingredients:
fluticasone propionate

Dosage form:
Inhalation, pressurised

Sponsor:
Cipla Australia Pty Ltd

Phone:
0396964413

From
03 Nov 2023
to
15 Oct 2024

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing

FLIXONASE NASULE DROPS fluticasone propionate 400mcg unit dose ampoule strip pack
AUST R: 71294
Active ingredients:
fluticasone propionate

Dosage form:
Nasal Drops

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

Deletion from market:
15 Jul 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Patients are advised to consult their healthcare professionals to discuss alternative treatment options.

FLIXOTIDE NEBULES fluticasone propionate 0.5mg/2mL inhalation ampoule
AUST R: 69004
Active ingredients:
fluticasone propionate

Dosage form:
Inhalation, conventional

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

Deletion from market:
26 Feb 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Patients are advised to consult their healthcare professionals to discuss alternative treatment options.

FLIXOTIDE NEBULES fluticasone propionate 2.0mg/2mL inhalation ampoule
AUST R: 69002
Active ingredients:
fluticasone propionate

Dosage form:
Inhalation, conventional

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

Deletion from market:
19 Nov 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Patients are advised to consult their healthcare professionals to discuss alternative treatment options.